
ESOPNov 20, 2026, 04:01 PM
Avalo Therapeutics Grants Stock Options to New Employees
AI Summary
Avalo Therapeutics, Inc. announced the grant of inducement equity awards to three new employees. The Compensation Committee approved the grants of nonstatutory stock options to purchase an aggregate of 52,000 shares of common stock. These options have an exercise price of $6.70 per share and will vest over a period of up to four years, subject to continued employment. The company is focused on developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases.
Key Highlights
- Avalo Therapeutics granted stock options to 3 new employees.
- Options cover 52,000 shares of common stock.
- Exercise price is $6.70 per share, equal to the closing price on grant date.
- Options vest over 4 years: 25% after one year, then monthly over 36 months.
- Awards are inducements material to employment, per Nasdaq Listing Rule 5635(c)(4).
- Avalo is developing abdakibart for hidradenitis suppurativa (HS).
Price Impact
More from AVTX